ational postpartum psychosis prevention study
Completed
- Conditions
- 1003641110026753puerperal psychosispostpartum psychosis
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 310
Inclusion Criteria
- Age > 18 years
- A history of bipolar disorder and/or postpartum psychosis
- Women who are able to complete Dutch questionnaires;Offspring: between 2 and 5 years of age
Exclusion Criteria
None.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome will be peripartum relapse (during pregnancy or within 3 months<br /><br>postpartum): any episode fulfilling DSM-IV criteria for<br /><br>mania/depression/psychosis or any other episode, severe enough to warrant<br /><br>treatment.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Obstetric complications, neonatal adverse outcome, infant neurodevelopment.<br /><br>Blood cells and serum biomarkers predictive for relapse.</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie postpartum psychosis risk in the NL-OMON47010 observational study?
How does the NP3-Study compare to standard antipsychotic regimens for postpartum psychosis prevention?
Which biomarkers predict response to postpartum psychosis interventions in the Erasmus MC trial?
What adverse events are associated with postpartum psychosis prevention strategies in the NP3-Study cohort?
Are there novel combination therapies for postpartum psychosis prevention beyond the NP3-Study's scope?